We are live on ! Find out more
LUNG icon

Pulmonx

111 hedge funds and large institutions have $220M invested in Pulmonx in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

29% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 31

0.46% less ownership

Funds ownership: 89.97%89.5% (-0.46%)

6% less funds holding

Funds holding: 118111 (-7)

22% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 27

31% less capital invested

Capital invested by funds: $321M → $220M (-$101M)

Holders
111
Holders Change
-7
Holders Change %
-5.93%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
21
Increased
40
Reduced
31
Closed
27
Calls
$3K
Puts
Net Calls
+$3K
Net Calls Change
-$3K

LUNG Hedge Fund Activity: Q2 2024 in Review

111 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q2 2024, worth a combined $220M — down 31% from $321M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of LUNG and 21 opened new positions — a net loss of 6 holders — while 31 trimmed existing stakes and 40 added.

The largest buyer was Morgan Stanley, adding an estimated $6.3M. The largest seller was Point72 Asset Management, cutting an estimated $19M.

  • 111 institutional investors held Pulmonx (LUNG) as of Q2 2024, down from 118 in Q1 2024.
  • Funds reported $220M of Pulmonx stock for Q2 2024, down 31% quarter-over-quarter.
  • 21 funds opened new Pulmonx positions in Q2 2024 and 27 closed out, a net change of -6 holders.
  • The largest Pulmonx buyer in Q2 2024 was Morgan Stanley, an estimated $6.3M added.
  • The largest Pulmonx seller in Q2 2024 was Point72 Asset Management, an estimated $19M sold.

Based on aggregated 13F filings for Q2 2024.